A randomized phase II trial of adjuvant chemotherapy with gemcitabine versus S-1 after major hepatectomy for biliary tract cancer: Kansai Hepato-Biliary Oncology Group (KHBO1208)

被引：0

作者：

Terajima, H. ^{[1
]}

Kobayashi, S. ^{[2
]}

Nagano, H. ^{[3
]}

Tomokuni, A. ^{[4
]}

Gotoh, K. ^{[2
]}

Sakai, D. ^{[5
]}

Hatano, E. ^{[6
]}

Seo, S. ^{[7
]}

Uchida, Y. ^{[1
]}

Ajiki, T. ^{[8
]}

Satake, H. ^{[9
]}

Kamei, K. ^{[10
]}

Tohyama, T. ^{[11
]}

Hirose, T. ^{[12
]}

Ikai, I. ^{[13
]}

Morita, S. ^{[14
]}

Ioka, T. ^{[15
]}

机构：

[1] Kitano Hosp, Tazuke Kofu Kai Med Res Inst, Dept Gastroenterol Surg & Oncol, Osaka, Japan

[2] Osaka Univ, Grad Sch Med, Dept Surg, Suita, Osaka, Japan

[3] Yamaguchi Univ, Grad Sch Med, Dept Gastroenterol Breast & Endocrine Surg, Yamaguchi, Japan

[4] Osaka Int Canc Inst, Dept Surg, Osaka, Japan

[5] Osaka Univ, Dept Frontier Sci Canc & Chemotherapy, Grad Sch Med, Suita, Osaka, Japan

[6] Hyogo Coll Med, Dept Surg, Nishinomiya, Hyogo, Japan

[7] Kyoto Univ, Dept Surg, Grad Sch Med, Kyoto, Japan

[8] Kobe Univ, Grad Sch Med, Div Hepatobiliary Pancreat Surg, Dept Surg, Kobe, Hyogo, Japan

[9] Gen Hosp, Kobe City Med Ctr, Dept Med Oncol, Kobe, Hyogo, Japan

[10] Kindai Univ, Fac Med, Dept Surg, Osakasayama, Japan

[11] Ehime Univ, Dept Hepatobiliary Pancreat & Breast Surg, Grad Sch Med, Touon, Japan

[12] Otsu Red Cross Hosp, Dept Surg, Otsu, Shiga, Japan

[13] Natl Hosp Org Kyoto Med Ctr, Dept Surg, Kyoto, Japan

[14] Kyoto Univ, Dept Biomed Stat & Bioinformat, Grad Sch Med, Kyoto, Japan

[15] Osaka Int Canc Inst, Dept Canc Survey & Gatrointestinal Oncol, Osaka, Japan

来源：

ANNALS OF ONCOLOGY | 2018年 / 29卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

762P

引用

页数：1

共 50 条

[21] Phase II study of gemcitabine and S-1 combination chemotherapy in patients with metastatic biliary tract cancer
Hyeong Su Kim
Ho Young Kim
Dae Young Zang
Ho Suk Oh
Jang Yong Jeon
Ji Woong Cho
Choong Kee Park
Jong Hyeok Kim
Min-Jeong Kim
Hong Il Ha
Jung Han Kim
Boram Han
Hunho Song
Jung Hye Kwon
Dae Ro Choi
Joo Young Jung
Cancer Chemotherapy and Pharmacology, 2015, 75 : 711 - 718
[22] A multicenter phase II study of gemcitabine plus S-1 chemotherapy for advanced biliary tract cancer
Arima, S.
Shimizu, K.
Okamoto, T.
Toki, S.
Kasuga, A.
Kitamura, H.
Takasu, A.
Nagashima, F.
Sugiyama, M.
Furuse, J.
EUROPEAN JOURNAL OF CANCER, 2013, 49 : S627 - S627
[23] A Multicenter Phase II Study of Gemcitabine plus S-1 Chemotherapy for Advanced Biliary Tract Cancer
Arima, Shiho
Shimizu, Kyoko
Okamoto, Tomoyoshi
Toki, Masao
Suzuki, Yutaka
Okano, Naohiro
Naruge, Daisuke
Kawai, Kirio
Kobayashi, Takaaki
Kasuga, Akiyoshi
Kitamura, Hiroshi
Takasu, Atuko
Nagashima, Fumio
Sugiyama, Masanori
Furuse, Junji
ANTICANCER RESEARCH, 2017, 37 (02) : 909 - 914
[24] Phase I study of adjuvant chemotherapy with gemcitabine plus cisplatin in patients with biliary tract cancer undergoing curative resection without major hepatectomy (KHBO1004)
Toyoda, Masanori
Ajiki, Tetsuo
Fujiwara, Yutaka
Nagano, Hiroaki
Kobayashi, Shogo
Sakai, Daisuke
Hatano, Etsuro
Kanai, Masashi
Nakamori, Shoji
Miyamoto, Atsushi
Tsuji, Akihito
Kaihara, Satoshi
Ikoma, Hisashi
Takemura, Shigekazu
Toyokawa, Hideyoshi
Terajima, Hiroaki
Morita, Satoshi
Ioka, Tatsuya
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (06) : 1295 - 1301
[25] A phase II trial of oral S-1 combined with gemcitabine in patients with unresectable biliary tract cancer
Nakamura, K.
Yamaguchi, T.
Sudo, K.
Hara, T.
Denda, T.
Azemoto, R.
Ishihara, T.
Tsuyuguchi, T.
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
[26] PHASE II TRIAL OF GEMCITABINE AND S-1 COMBINATION FOR PATIENTS WITH ADVANCED PANCREAS AND BILIARY TRACT CANCER
Zang, D. Y.
Kim, J. H.
Hwang, S. W.
Kim, H. Y.
Kim, H. J.
Song, H. H.
Jung, J. Y.
Kwon, J. H.
Park, S.
ANNALS OF ONCOLOGY, 2008, 19 : 185 - 185
[27] Phase I study of adjuvant chemotherapy with gemcitabine plus cisplatin in patients with biliary tract cancer undergoing curative resection without major hepatectomy (KHBO1004)
Masanori Toyoda
Tetsuo Ajiki
Yutaka Fujiwara
Hiroaki Nagano
Shogo Kobayashi
Daisuke Sakai
Etsuro Hatano
Masashi Kanai
Shoji Nakamori
Atsushi Miyamoto
Akihito Tsuji
Satoshi Kaihara
Hisashi Ikoma
Shigekazu Takemura
Hideyoshi Toyokawa
Hiroaki Terajima
Satoshi Morita
Tatsuya Ioka
Cancer Chemotherapy and Pharmacology, 2014, 73 : 1295 - 1301
[28] Phase I study of adjuvant chemotherapy with gemcitabine plus cisplatin in patients with biliary tract cancer undergoing curative resection without major hepatectomy (KHBO1004)
Toyoda, Masanori
Ajiki, Tetsuo
Fujiwara, Yutaka
Nagano, Hiroaki
Kobayashi, Shogo
Sakai, Daisuke
Hatano, Etsuro
Kanai, Masashi
Nakamori, Shoji
Miyamoto, Atsushi
Tsuji, Akihito
Kaihara, Satoshi
Ikoma, Hisashi
Takemura, Shigekazu
Toyokawa, Hideyoshi
Terajima, Hiroaki
Ioka, Tatsuya
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
[29] A multi-institution phase II study of gemcitabine/cisplatin/S-1 (GCS) combination chemotherapy for patients with advanced biliary tract cancer (KHBO 1002)
Masashi Kanai
Etsuro Hatano
Shogo Kobayashi
Yutaka Fujiwara
Shigeru Marubashi
Atsushi Miyamoto
Hisanori Shiomi
Shoji Kubo
Shinichi Ikuta
Hiroaki Yanagimoto
Hiroaki Terajima
Hisashi Ikoma
Daisuke Sakai
Yuzo Kodama
Satoru Seo
Satoshi Morita
Tetsuo Ajiki
Hiroaki Nagano
Tatsuya Ioka
Cancer Chemotherapy and Pharmacology, 2015, 75 : 293 - 300
[30] A multi-institution phase II study of gemcitabine/cisplatin/S-1 (GCS) combination chemotherapy for patients with advanced biliary tract cancer (KHBO 1002)
Kanai, Masashi
Hatano, Etsuro
Kobayashi, Shogo
Fujiwara, Yutaka
Marubashi, Shigeru
Miyamoto, Atsushi
Shiomi, Hisanori
Kubo, Shoji
Ikuta, Shinichi
Yanagimoto, Hiroaki
Terajima, Hiroaki
Ikoma, Hisashi
Sakai, Daisuke
Kodama, Yuzo
Seo, Satoru
Morita, Satoshi
Ajiki, Tetsuo
Nagano, Hiroaki
Ioka, Tatsuya
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (02) : 293 - 300

← 1 2 3 4 5 →